Stay updated on Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial

Sign up to get notified when there's something new on the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-06T09:28:44.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.
    Difference
    0.6%
    Check dated 2025-05-30T00:31:19.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-22T21:54:40.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The webpage has removed significant content related to a clinical study, including the study's title, sponsor information, and various details about the study's design and eligibility criteria.
    Difference
    91%
    Check dated 2025-05-08T13:09:04.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-05-01T05:52:21.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates regarding the clinical trial for Type 2 Diabetes Mellitus, including the addition of specific treatment protocols and randomization processes for subjects based on their HbA1c levels. The previous version's detailed objectives and inclusion/exclusion criteria have been removed, indicating a shift in focus towards the treatment outcomes and procedures.
    Difference
    23%
    Check dated 2025-04-16T14:47:41.000Z thumbnail image

Stay in the know with updates to Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page.